Influenza vaccination in children being treated with chemotherapy for cancer

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 8, 2013, Pages

  Goossen, Ginette M ^a   Kremer, Leontien C M ^b   van de Wetering, Marianne D ^b  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; INFLUENZA VACCINE; PLACEBO;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIBODY TITER; ASTHMA; CANCER CHEMOTHERAPY; DRUG EFFICACY; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VACCINATION; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; CHILD; CONTROLLED CLINICAL TRIAL (TOPIC); IMMUNOLOGY; INFLUENZA, HUMAN; NEOPLASMS; VACCINATION; NEOPLASM;

ANTINEOPLASTIC AGENTS; CHILD; CONTROLLED CLINICAL TRIALS AS TOPIC; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; NEOPLASMS; VACCINATION;

EID: 84893343487     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006484.pub3     Document Type: Review

References (64)

1. Chisholm JC, Devine T, Charlett A, Pinkerton CR, Zoambon M. Response to influenza immunisation during treatment for cancer. Archives of Disease in Childhood 2001;84(6):496-500.
2. Chisholm J, Howe K, Taj M, Zambon M. Influenza immunization in children with solid tumours. European Journal of Cancer 2005;41(15):2280-7.
3. Gross PA, Lee H, WolffJA, Hall CB, Minnefore AB, Lazicki ME. Influenza immunization in immunosuppressed children. Journal of Pediatrics 1978;92(1):30-5.
4. Hsieh Y, Lu MY, Kao CL, Chiang BL, Lin DT, Lin KS, et al. Response to influenza vaccine in children with leukemia undergoing chemotherapy [RCT]. Journal of the Formosan Medical Association 2002;101(10):700-4.
5. Hsieh Y, Lu MY, Kao CL, Chiang BL, Lin DT, Lin KS, et al. Response to influenza vaccine in children with leukemia undergoing chemotherapy [CCT]. Journal of the Formosan Medical Association 2002;101(10):700-4.
6. Lange B, Shapiro SA, Waldman MT, Proctor E, Arbeter A. Antibody responses to influenza immunization of children with acute lymphoblastic leukemia. Journal of Infectious Diseases 1979;140(3):402-6.
7. Matsuzaki A, Suminoe A, Koga Y, Kinukawa N, Kusuhara K, Hara T. Immune response after influenza vaccination in children with cancer. Pediatric Blood & Cancer 2005;45(6):831-7.
8. Porter CC, Edwards KM, Zhu Y, Frangoul H. Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia. Pediatric Blood & Cancer 2004;42(1):36-40.
9. Shahgholi E, Ehsahni MA, Salamati P, Maysamie A, Sotoudeh K, Mokhtariazad T. Immunogenicity of trivalent influenza vaccine in children with acute lymphoblastic leukemia during maintenance therapy. Pediatric Blood and Cancer 2010;54(5):716-20.
10. Steinherz PG, Brown AE, Gross PA, Braun D, Ghavimi F, Wollner N, et al. Influenza immunization of children with neoplastic diseases. Cancer 1980;45(4):750-6.
11. Adell C, Bayas JM, Vilella A, Perales M, Vidal J, Bertran MJ, et al. Post-transplantation vaccination of bone-marrow transplant recipients [Vacunación de pacientes receptores de trasplante de progenitores hemotopyéticos]. Medicina Clínica 2002;119(11):405-9.
12. Ahmed AH, Nicholson KG. The efficacy of influenza vaccine. Reviews in Medical Microbiology 1996;7(1):23-30.
13. Allison JE, Glezen WP, Taber LH, Paredes A, Webster RG. Reactogenicity and immunogenicity of bivalent influenza A and monovalent influenza B virus vaccines in high-risk children. Journal of Infectious Diseases 1977;136 Suppl:S672-6.
14. Arola M, Ruuskanen O, Ziegler T, Salmi TT. Respiratory virus infections during anticancer treatment in children. Pediatric Infectious Disease Journal 1995;14(8):690-4.
15. Barnes R, Stallard N. Severe infections after bone marrow transplantation. Current Opinion in Critical Care 2001;7(5):362-6.
16. Bektas O, Karadeniz C, Oguz A, Berberoglu S, Berberoglu S, Yilmaz N, et al. Assessment of the immune response to trivalent split influenza vaccine in children with solid tumors. Pediatric Blood and cancer 2007;49(7):914-7.
17. Borella L, Webster RG. The immunosuppressive effects of long-term combination chemotherapy in children with acute leukemia in remission. Cancer Research 1971;31(4):420-6.
18. Brown AE, Steinherz PG, Miller DR, Armstrong D, Kellick G, Gross PA, et al. Immunization against influenza in children with cancer: results of a three-dose trial. Journal of Infectious Diseases 1982;145(1):126.
19. Brown AE. Influenza and pneumococcal immunization of patients with neoplastic diseases. Schweizerische Medizinische Wochenschrift Supplementum 1983;14:30-4.
20. Brunell PA. Immunologic response of immunosuppressed children to influenza vaccine. Morbidity and Mortality Weekly Report 1977;26:54.
21. Brydak LB, Rokicka-Milewska R, Jackowska T, Rudnicka H, Regnery H, Cox N. Kinetics of humoral response in children with acute lymphoblastic leukemia immunized with influenza vaccine in 1993 in Poland. Leukemia and Lymphoma 1997;26(1-2):163-9.
22. Brydak LB, Rokicka-Milewska R, Machala M, Jackowska T, Sikorska-Fic B. Immunogenicity of subunit trivalent influenza vaccine in children with acute lymphoblastic leukemia. Pediatric Infectious Disease Journal 1998;17(2):125-9.
23. Engelhard D, Nagler A, Hardan I, Morag A, Aker M, Baciu H, et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplantation 1993;11(1):1-5.
24. Esposito S, Cecinati V, Russo FG, Principi N. Influenza vaccination in children with cancer receiving chemotherapy. Human Vaccination 2009;5(6):430-2.
25. Feery BJ, Matthews RN, Evered MG, Gallichio HA. Antibody responses to influenza virus vaccine in patients with acute lymphocytic leukaemia. Australian Paediatric Journal 1979;15(3):177-80.
26. Ganz PA, Shanley JD, Cherry JD. Responses of patients with neoplastic diseases to influenza virus vaccine. Cancer 1978;42(5):2244-7.
27. Gribabis DA, Panayiotidis P, Boussiotis VA, Hannoun C, Pangalis GA. Influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients. Acta Haematologica 1994;91(3):115-8.
28. Gross PA, Gould AL, Brown AE. Effect of chemotherapy on the immune response to influenza virus vaccine: review of published studies. Review of Infectious Diseases 1985;7(5):613-8.
29. Hayden FG. Advances in the prophylaxis and treatment of influenza illness. American Journal of Managed Care 2000;6(5 Suppl):S247-54.
30. Hicks KL, Chemaly RF, Kontoyiannis DP. Common respiratory viruses in patients with cancer: more than just "common colds". Cancer 2003;97(10):2576-87.
31. Jackowska T, Brydak L, Rokicka-Milewska R, Lukowska K, Gosk B, Rudnicka H, et al. Vaccination against influenza in children with acute lymphoblastic leukaemia [Szczepienia przeciw grypie dzieci chorych na ostra bialaczke limfoblastyczna]. Pediatria Polska 1996;71(4):302-6.
32. Kandel R, Hartshorn KL. Novel strategies for prevention and treatment of influenza. Expert Opinion on Therapeutic Targets 2005;9(1):1-22.
33. Kempe A, Hall CB, MacDonald NE, Foye HR, Woodin KA, Cohen HJ, et al. Influenza in children with cancer. Journal of Pediatrics 1989;115(1):33-9.
34. Louie JK, Schechter R, Honarmand S, Guevara HF, Schoemaker TR, Madrigal NY, et al. Severe pediatric influenza in California, 2003-2005: implications for immunization recommendations. Pediatrics 2006;117(4):e610-8.
35. Mayr AC, Nagel GA, Dick HJ, Pavlicek LP. Proceedings: influenza vaccination in patients with cancer? [Grippeschutzimpfung bei Tumorpatienten?]. Helvetica Medica Acta 1974;37(5-6):395.
36. McIntosh ED, Paradiso PR. Recent progress in the development of vaccines for infants and children. Vaccine 2003;21(7-8):601-4.
37. Modlin JF, Smith DH, Harding L. Clinical trials of bivalent A/New Jersey/76-A/Victoria/75 influenza vaccines in high-risk children. Journal of Infectious Diseases 1977;136 Suppl:S626-31.
38. Morris DJ. Virus infections in children with cancer. Reviews in Medical Microbiology 1990;1(1):49-57.
39. Pauksen K, Linde A, Hammarström V, Sjölin J, Carneskog J, Jonsson G, et al. Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients. Clinical Infectious Diseases 2000;30(2):342-8.
40. Reilly A, Kersun LS, McDonald K, Weinberg A, Jawad AF, Sullivan KE. The efficacy of influenza vaccination in a pediatric oncology population. Journal of Pediatric Hematology Oncology 2010;32(5):e177-81.
41. Ridgway D, WolffLJ. Active immunisation of children with leukemia and other malignancies. Leukemia and Lymphoma 1993;9(3):177-92.
42. Schafer AI, Churchill WH, Ames P, Weinstein L. The influence of chemotherapy on response of patients with hematologic malignancies to influenza vaccine. Cancer 1979;43(1):25-30.
43. Smithson WA, Siem RA, Ritts RE, Gilchrist GS, Burgert EO, Ilstrup DM, et al. Response to influenza virus vaccine in children receiving chemotherapy for malignancy. Journal of Pediatrics 1978;93(4):632-4.
44. Somani J, Larson RA. Reimmunization after allogeneic bone marrow transplantation. American Journal of Medicine 1995;98(4):389-98.
45. Stiver HG, Weinerman BH. Impaired serum antibody response to inactivated influenza A and B vaccine in cancer patients. Canadian Medical Association Journal 1978;119(7):733-8.
46. Sumaya CV, Williams TE, Brunell PA. Bivalent influenza vaccine in children with cancer. Journal of Infectious Diseases 1977;136 Suppl:S656-60.
47. Sumaya CV, Williams TE. Persistence of antibody after the administration of influenza vaccine to children with cancer. Pediatrics 1982;69(2):226-9.
48. Uchaikin VF, Skachkova LO, Shamsheva OV, Smirnov AV, Polesko IV, Lezhneva LN, et al. The vaccination of children with severe somatic pathology [Vaktsinatsiia detei s tiazheloi somaticheskoi patologiei]. [Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii] 1999;4:30-4.
49. Yamada A, Yamawaki H, Tsuda N, Baba K, Yabuuchi H, Maeda A, et al. Trial of split-product trivalent influenza vaccine in high risk children. Biken Journal 1982;25(2):89-95.
50. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. The Cochrane Library, Issue 3. Chichester, UK: John Wiley & Sons, Ltd, 2005.
51. Collins J, Byrnes M, Dunkel I, Lapin J, Nadel T, Thaler H, et al. The measurement of symptoms in children with cancer. Journal of Pain and Symptom Management 2000;19(5):323-77.
52. Dykewicz CA. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: focus on community respiratory virus infections. Biology of Blood and Marrow Transplantation 2001;7 Suppl:19S-22S.
53. Feldman S, Webster RG, Sugg M. Influenza in children and young adults with cancer. Cancer 1977;39:350-3.
54. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. Morbidity and Mortality Weekly Report; Recommendations and Reports 2010;59(31):1-62.
55. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0 [updated July 2008]. The Cochrane Collaboration.www.cochrane-handbook.org, 2008.
56. Karadeniz C, Karadeniz C, Bektas O, Oguz A, Berberoglu S, Yy'maz N, et al. P.G1.015 Responses of children with solid tumours to influenza virus vaccine. 37th Annual Conference of the International Society of Paediatric Oncology, SIOP 2005, Vancouver, Canada, 21-24 September 2005. Pediatric Blood & Cancer. 2005; Vol. 45:4.
57. Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. Newcastle Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses, 2007. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
58. Potter MN, Foot ABM, Oakhill A. Influenza A and the virus associated haemophagocytic syndrome: cluster of three cases in children with acute leukaemia. Journal of Clinical Pathology 1991;44:297-9.
59. Raad I, Abbas J, Whimbey E. Infection control of nosocomial respiratory viral disease in the immunocompromised host. American Journal of Medicine 1997;102:48-52.
60. The Nordic Cochrane Centre. The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration, 2008.
61. Ring A, Gavin M, Steer C, Harper P. Influenza vaccination and chemotherapy: a shot in the dark?. Supportive Care in Cancer 2002;10:462-5.
62. Sandherr M, Einsele H, Hebart H, Kahl C, Kern W, Kiehl M, et al. Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO). Annals of Oncology 2006;17(7):1051-9.
63. Goossen GM, Kremer LCM, van de Wetering MD. Influenza vaccination in children being treated with chemotherapy for cancer. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD006484]
64. Goossen GM, Kremer LCM, van de Wetering MD. Influenza vaccination in children being treated with chemotherapy for cancer. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD006484.pub2]